Why Is NIKE INC Class B (NKE) Stock Down Today?

Nike Inc. Class B (NKE) fell 6.19% to $32.97 in early trading on Monday, marking one of the largest single-day declines in recent weeks. The stock opened with a 10.3% gap down from the previous close of $35.15 and traded in a narrow range throughout the session. The drop followed a series of analyst rating cuts and price target reductions, as well as a disappointing revenue report and weaker-than-expected guidance from the company.

What Happened

Truist cut Nike’s price target to $29 from $42, while Piper Sandler and Williams Trading also reduced their price targets following a revenue miss in the first quarter. Nike’s management guided for significantly lower sales, which fell below Wall Street expectations. The stock has already declined about 80% from its peak, and the recent earnings shortfall has intensified concerns about the company’s ability to reverse its long-term trend. Analysts from RBC Capital and Guggenheim also adjusted their price targets, with some maintaining a cautious stance while others lowered their forecasts. Meanwhile, several top executives, including EVPs Venkatesh, McCartney, and Leinwand, sold shares on September 9, adding to investor unease.

What The Data Shows

Nike’s stock opened at $31.52 and reached a low of $31.45, with a high of $35.15 at the session open. The stock traded at $33.05 at the time of the report, with 30.3 million shares changing hands, 1.1 times the 3-month average. The company has a market cap of $52.5 billion, a P/E ratio of 16.7, and a dividend yield of 4.63%. Over the last eight trading sessions, the stock has fallen 2.5% from $36.56 to $35.65. Recent insider transactions show 8 sales totaling $771,000 in the last 90 days. On the options front, $12.1 million in put premiums were traded versus $5.2 million in calls, with the largest single print valued at $2.2 million.

What To Watch

Nike is expected to report quarterly earnings in the coming months, and the market will closely monitor how the company addresses its ongoing challenges, including its performance in China and the broader athletic footwear market. Analyst coverage remains mixed, with some firms maintaining cautious optimism while others cut their price targets.